DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 91 filers reported holding DYNE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $19,271,000 | -28.7% | 2,805,045 | 0.0% | 0.51% | -12.9% |
| Q1 2022 | $27,041,000 | -18.9% | 2,805,045 | 0.0% | 0.59% | +0.3% |
| Q4 2021 | $33,352,000 | -26.8% | 2,805,045 | 0.0% | 0.59% | -6.8% |
| Q3 2021 | $45,554,000 | -22.8% | 2,805,045 | 0.0% | 0.63% | -33.4% |
| Q2 2021 | $59,018,000 | +35.5% | 2,805,045 | 0.0% | 0.95% | +44.1% |
| Q1 2021 | $43,562,000 | -26.0% | 2,805,045 | 0.0% | 0.66% | -20.2% |
| Q4 2020 | $58,906,000 | +4.0% | 2,805,045 | 0.0% | 0.82% | -20.6% |
| Q3 2020 | $56,634,000 | – | 2,805,045 | – | 1.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,220,034 | $25,730,194 | 34.58% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $57,385,602 | 24.01% |
| Atlas Venture Life Science Advisors, LLC | 9,869,483 | $114,387,308 | 13.78% |
| Logos Global Management LP | 2,150,000 | $24,918,500 | 2.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 641,068 | $7,417,157 | 2.29% |
| Deep Track Capital, LP | 2,684,200 | $31,109,878 | 1.31% |
| EcoR1 Capital, LLC | 2,322,384 | $26,916,431 | 0.82% |
| Vivo Capital, LLC | 577,642 | $6,695 | 0.77% |
| HighVista Strategies LLC | 102,431 | $1,187,175 | 0.70% |
| Monashee Investment Management LLC | 123,719 | $1,433,903 | 0.62% |